Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular xenotransplantation

P Aebischer, A F Hottinger, N Déglon

    Nature Medicine
    |July 30, 1999
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gene editing as a therapeutic strategy for spinocerebellar ataxia type-3.

    Revue neurologique·2024
    Same author

    Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.

    Journal of neuro-oncology·2022
    Same author

    Malignant PRES and RCVS after brain surgery in the early postpartum period.

    Clinical neurology and neurosurgery·2019
    Same author

    Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma.

    British journal of cancer·2018
    Same journal

    Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

    Nature medicine·2026
    Same journal

    Immune aging biomarkers for clinical trials.

    Nature medicine·2026
    Same journal

    Lassa fever countermeasures gather pace.

    Nature medicine·2026
    Same journal

    Why high scores do not mean application readiness for health AI.

    Nature medicine·2026
    Same journal

    Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

    Nature medicine·2026
    Same journal

    Biological aging might help to explain the rising risk of early-onset cancer.

    Nature medicine·2026
    See all related articles